Search 1
Entities
LogoName Σ Employees
Recursion Recursion

Decoding Biology to Radically Improve Lives We are a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded. While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt …

Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

11 2 9 569
ABEC ABEC

engineered solutions and services for biotech manufacturing ABEC engineered solutions and services for biotech manufacturing Since 1974, ABEC has been a global leader in delivering integrated process solutions and services for manufacturing in the biopharmaceutical industry. Many of today’s leading antibody, vaccine, and recombinant protein therapies are manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC, and a majority of the world’s pharmaceutical and biotech companies are ABEC customers. ABEC’s unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether building new capacity or improving existing facilities, ABEC’s turn-key …

Type: SMB Activities: deeptech IT Services Technologies: Synthetic Biology

1 0 1 582
Parkinson's UK Parkinson's UK

We’ll find a cure. Together. Powered by people. Funded by you. Improving life for everyone affected by Parkinson’s. Your mum, colleague or friend. Anyone can get Parkinson’s, young or old. Every hour, two more people are diagnosed. Unlocking new treatments means delving into the causes of Parkinson’s. That’s why we fund the Parkinson's UK Brain Bank – the world's only brain bank dedicated to Parkinson's research. Over 10,000 people have donated their brains to help scientists around the world to unravel the mysteries of the condition and develop better treatments. The largest charitable funder of Parkinson’s research in Europe, we’re …

Type: SMB Activities: healthtech biotech silvertech deeptech fintech Technologies: Synthetic Biology

1 0 0 586
bluebird bio bluebird bio

Pursuing curative gene therapies to give patients and their families more bluebird days. bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. With a dedicated focus on severe genetic diseases, bluebird has industry-leading programs for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. We custom design each of our therapies to address the underlying cause of disease and have developed in-depth and effective analytical methods to understand the safety of our lentiviral vector technologies and drive the field of gene therapy …

Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

11 1 4 590
Amicus Therapeutics Amicus Therapeutics

Our passion for making a difference unites us. We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Amicus is the Latin word for friend. This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way. Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease. That spirit of empathy, compassion, and tenacity permeates our culture …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 590
Crown Bioscience Crown Bioscience

We support drug discovery through translational research across oncology and immuno-oncology. Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) providing discovery, preclinical, and translational platforms to advance oncology and immuno-oncology. Known for their high quality and expansive in vivo, in vitro and ex vivo preclinical models, they partner with their clients to quantify the efficacy and pharmacological profile of their drug candidate before they move into the clinic. The company is the only preclinical CRO to provide tumor organoid services utilizing HUB technology and has the world’s largest commercially available PDX collection. Additionally, further …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 0 2 590
Urgo Medical Urgo Medical

Make a difference by helping healthcare professionals heal patients Urgo Medical is the wound-healing division of URGO group. Every day our 1600 employees are passionate about creating, developing and promoting highly innovative dressings and global solutions to heal people suffering from wounds. Our mission, as The Healing Company, is to make a significant difference for patients, healthcare professionals and the healthcare systems. In order to fulfil our mission: • Patient is at the heart of everything we do. • We keep innovating to develop the best in class solutions. • We have a pioneer and entrepreneurial mindset and we dare …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

1 1 0 591
NanoString Technologies, Inc. NanoString Technologies, Inc.

Mapping the universe of biology 🧬 NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company's technology enables a wide variety of basic research and translational medicine applications. NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

2 0 2 610
Sopharma Sopharma

We have an active and crucial role in raising standards of everyday life, in making people healthier, happier and safer. Sopharma PLC is one of the leading pharmaceuticals company in Bulgaria popular with manufacturing of high-quality medicines, modern businessethic and social responsibility. The highly technological process for development and production of our products is licensed according to the GPP - Good Production Practices.

Type: SMB Activities: deeptech Technologies: Synthetic Biology

0 0 0 612
Valneva Valneva

Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines. …

Type: Startup Activities: biotech healthtech manufacturing Technologies: Synthetic Biology

22 9 5 623
Sage Therapeutics Sage Therapeutics

Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more …

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

8 2 4 625
ADVANZ PHARMA ADVANZ PHARMA

Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more …

Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

1 0 1 630
Kyowa Kirin, Inc.- U.S. Kyowa Kirin, Inc.- U.S.

Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes three offices in New Jersey and California that focus on drug discovery, product development, and commercialization. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 0 2 632
Hendrix Genetics Hendrix Genetics

Better Breeding Today. Brighter Life Tomorrow. Hendrix Genetics is a leading multi-species animal breeding company with primary activities in layer-, turkey-, traditional poultry-, swine-, trout and salmon breeding. Backed by a strong portfolio of leading brands, Hendrix Genetics provides expertise and resources to producers in more than 100 countries, with operations and joint ventures in 24 countries and more than 2.880 employees worldwide. Creating value with genetics is the essence of our existence. The three key components of how we create value for the animal protein chain are: collaboration, innovation and sustainability. We see collaboration as a key factor in …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

2 0 0 651
CareDx, Inc. CareDx, Inc.

Dedicated to transplant patients. Leading with innovation. CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure …

Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

2 0 1 658
Centre hospitalier Métropole Savoie - CHMS Centre hospitalier Métropole Savoie - CHMS

[Automatic translation follows] The CHMS is located in Chambéry and Aix-les-Bains. It is the support establishment for the GHT Savoie/Belley. A benchmark establishment for the Savoie Belley region, the Métropole Savoie hospital center is located on two sites in Chambéry and Aix-les-Bains. Each year, the two adult emergency departments, the pediatric emergencies and the gynecological emergencies welcome more than 94,000 patients 24 hours a day. The Emergency department includes the only adult intensive care unit in the region. Its recent technical platform makes it possible to carry out almost all diagnostic and therapeutic procedures. All types of surgery are performed, …

Type: SMB Activities: healthtech Technologies: SaaS Synthetic Biology

3 3 0 658
Revance Revance

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences. Botulinum Toxin, biotechnology, biotech, healthcare, pharmaceuticals, science, research, financial services, and fintech

Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

2 1 1 659
Frontage Laboratories, Inc Frontage Laboratories, Inc

Advancing drug discovery and development through integrated laboratory, analytical, and clinical services Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

0 0 0 661
Sygnature Discovery Sygnature Discovery

Sygnature Discovery is a world-leading integrated drug discovery Contract Research Organisation, with over 1000 staff from 53 nationalities, including 900 scientists working on drug discovery programmes. Founded in 2004, we have delivered over 40 pre-clinical compounds, 21 clinical compounds, and our scientists are named on over 170 patent applications. We partner with global pharma, biotech, and NFP organizations, providing integrated drug discovery services from target identification through to candidate nomination. Our co-located teams are experts in protein science, chemistry, computational chemistry, in vitro biology, pharmacology, DMPK, form and formulation services, and project management, with a core therapeutic focus on oncology, …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

9 0 6 684
CenExel CenExel

Reaching new heights in clinical research by offering medical & scientific support in clinical trial design & execution. CenExel Centers of Excellence is proud to support a variety of clinical research as a network which includes; CenExel ACT, ACMR, AMRI, CBH, CIT, CNR, CNS, FCR, HRI, iResearch, JBR and RCA. Visit the bio link to learn more about the indications we support and how CenExel can help your clinical trial be successful. clinicalresearch, Healthcare, clinicaltrials, medicalresearch, pharmaceutical, scientificresearch, Mental health, PTSD, Bipolar, Schizophrenia, Alzheimers, Bunions, Pediatric Psychiatry, Migraines, Depression, analgesics, medication, pain relief, doctors, patient care, therapeutic research, Vaccination, Neurology, …

Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

9 0 1 686
Corin Group Corin Group

Helping orthopaedic surgeons enhance patient well-being with our proven implants, connected technologies and data. As a leader in orthopaedic innovation, Corin has pioneered a number of landmark developments since its foundation and is proud to have been able to improve the quality of life of thousands of patients around the world through these groundbreaking products. The company’s talented and dedicated teams share a common commitment to deliver quality orthopaedic products and services to patients, surgeons and healthcare providers which exceed expectations and positively impact lives. With an increasingly active and demanding patient population, the need to provide state of the …

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

0 0 0 689
CARBOGEN AMCIS CARBOGEN AMCIS

BRINGING YOUR SCIENCE TO LIFE CARBOGEN AMCIS leverages its world-class chemistry skills to provide seamless drug substance, drug products development and commercialization services for leading pharmaceutical and biopharmaceutical companies. We help customers create a better world by becoming the partner of choice thanks to our innovative solutions. We offer an array of integrated and customized services operating in a fully cGMP-compliant infrastructure, including dedicated Highly Potent API facilities and a clean room for Antibody Drug Conjugates. Beyond our services, we also provide high-quality Cholesterol and Vitamin D analogs. CARBOGEN AMCIS is owned by Dishman Carbogen Amcis Limited, (India). Learn more …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

5 3 1 700
Excelya Excelya

Expertly delivering clinical trials operations, with care. Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence. Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, …

Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

8 2 3 702
Selvita Selvita

Integrated Drug Discovery | Drug Development | Contract Research Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 0 1 702
Blueprint Medicines Blueprint Medicines

Striving to improve and extend patient lives Blueprint Medicines is a fully integrated, commercial-stage, global biopharmaceutical company that invents life-changing medicines in two core, strategic areas of allergy/inflammation and oncology/hematology. We pursue discovery, development, and commercialization of therapies that potently and selectively target known drivers of disease, with focused investment in therapeutic areas where we can leverage our core expertise and business infrastructure to bring scale to our science. We are bringing an approved medicine to people living with systemic mastocytosis (SM) in the U.S. and Europe. Additionally, we have a pipeline of research and development programs that range from …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

5 0 2 708
New England Biolabs New England Biolabs

be INSPIRED, drive DISCOVERY, stay GENUINE Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 3 0 719
Medscape Medscape

The leading online global destination for physicians and healthcare professionals: https://wb.md/2EPrMgZ Our Mission: To improve patient care with comprehensive clinical information and resources essential to physicians and healthcare professionals. Our Company: Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME. Medscape has over 30 distinct specialty sites for physicians, plus sites for nurses, pharmacists, dentists, and medical students. All content on Medscape.com and Medscape.org is available for free. medical news, medical reference, and continuing medical education

Type: SMB Activities: healthtech Technologies: Synthetic Biology

3 1 2 733
Oxford Biomedica Oxford Biomedica

A quality and innovation-led viral vector CDMO Oxford Biomedica (LSE: OXB) is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. The Company collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

4 0 4 737
Laboratoires Théa Laboratoires Théa

Théa, Let's Open Our Eyes Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free

Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

8 6 2 755
Molecular Devices Molecular Devices

Advancing Discovery Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

2 1 1 764
Carmat Carmat

Their life. Your skills. Our technology. CARMAT is a French MedTech that designs, manufactures and markets the Aeson® artificial heart. The Company’s ambition is to make Aeson® the first alternative to a heart transplant, and thus provide a therapeutic solution to people suffering from end-stage biventricular heart failure, who are facing a well-known shortfall in available human grafts. The world’s first physiological artificial heart that is highly hemocompatible, pulsatile and self-regulated, Aeson® could save, every year, the lives of thousands of patients waiting for a heart transplant. The device offers patients quality of life and mobility thanks to its ergonomic …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

3 0 3 774
Ajinomoto Bio-Pharma Services Ajinomoto Bio-Pharma Services

The Power to Make Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 775
Terumo Europe Terumo Europe

Advancing Healthcare and Enhancing Patients’ Quality of Life Terumo Europe is a core player in the EMEA healthcare market by providing best-in-class quality medical products and services. We are a strong actor of the Terumo Group by contributing to innovation and sustainable growth. Terumo Europe produces, distributes, markets, and sells a vast range of medical devices in five main business units: Interventional Systems, Pharmaceutical Solutions, Hospital Care Solutions, Cardiovascular and Life Care Solutions. Our headquarters are located in Leuven (Belgium). Terumo Europe committed to cultivating a globally diverse, equitable and inclusive culture. We empower everyone to bring their authentic self …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

1 1 0 807
PacBio PacBio

Our mission is to enable the promise of genomics to better human health. At PacBio, we’re devoted to empowering you. Pioneering the future through biology takes vision. You have to look beyond the status quo to what’s possible. We know your vision can reveal the full potential of the genome, advance human health and the health of our planet. And that is why your vision and pursuit are at the very center of what our company does — our product design, our customer support model, our partnerships, and even our identity. We create the world’s most advanced sequencing systems to …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

4 1 3 808
MEDGENOME MEDGENOME

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Labs is …

Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology

6 3 3 815
Sahajanand Medical Technologies Sahajanand Medical Technologies

Pledge to save millions We are a leading developer and manufacturer of minimally invasive coronary stent systems, with one of the broadest product portfolios in the industry. We have a strong international presence with footprints in more than75 countries. We at SMT believe in continuous innovation and up-gradation of our portfolio in order to cater your healthcare needs. Our commitment is to advance the patient care by introducing state of the art medical devices which will enable us to save precious lives. We are committed to the welfare of all the patients around the world. We are proud to be …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

0 0 0 821
Nephron Pharmaceuticals Nephron Pharmaceuticals

Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. NPC sells to many classes of trade, including, but not limited to, hospitals, pharmacies, long term care facilities, home care companies and mail order pharmacies. These medications are used in the treatment of asthma and COPD. Manufacturer of generic respiratory medications and Contract manufacturing blow-fill-seal medications

Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology

4 0 0 838
Rousselot Rousselot

Rousselot is the global leader of collagen-based solutions. Rousselot is Darling Ingredients' health brand. Rousselot: Reaching further together Rousselot is the global leader of collagen-based solutions* for the food, health and nutrition, biomedical and pharmaceutical sectors. We convert the full potential of the collagen molecule into solutions that sustain people’s health and well-being. Working in partnership with our global customer-base, we deliver advanced ingredient solutions that enable innovation, excite today’s consumers, and contribute to public health. Through our state-of-the-art operations, extensive technical expertise and sustained scientific research, we help our customers achieve their goals, create world-class products, and we “Reach …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

1 0 0 841
Dompé Dompé

We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

12 1 12 843
Device Technologies Device Technologies

Pioneering Possibility® For 31 years, Device Technologies has supplied the Australian healthcare community with quality and technologically advanced medical equipment, consumables, education and service. Proudly Australasian-owned, the company continues to grow, now employing more than 1000+ healthcare specialists and support staff across Australia, New Zealand, and Asia. In 2023, Device Technologies remains dedicated to the mission of enabling superior health outcomes for patients and their healthcare providers, by facilitating access to the best medical technology available worldwide. The company is united in its four core values to innovate, collaborate, take ownership, and consistently conduct good business. The extensive Device Technologies …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 848
CureVac CureVac

We fight for human health - we are the RNA people CureVac (Nasdaq: CVAC) is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing this versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of optimized mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases. In July 2020, CureVac entered in a collaboration with GSK to jointly develop new products in prophylactic vaccines for infectious …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

12 3 7 853
Eurofins Advinus Eurofins Advinus

Preferred Partner for Discovery and Development Services Eurofins Advinus Private Limited is a premier contract research, development and manufacturing organization (CRDMO) serving diverse industries to help advance their R&D programs within defined timelines with highest level of quality. With 30+ years of GLP experience, we have a proven track record of successfully delivering many integrated and stand-alone projects to meet our partner’s requirements. We offer a complete suite of drug discovery and development services. Our drug discovery services include medicinal and synthetic chemistry, ADMET/DMPK and Discovery Biology across various therapeutic areas. Our preclinical development services include process development, DMPK and …

Type: Large company Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

1 1 1 857
Sterling Pharma Solutions Sterling Pharma Solutions

Sterling Pharma Solutions is a leading provider of API services to the pharmaceutical industry. Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. Our facilities are located in Cramlington and Newcastle Biosphere, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology SaaS

1 0 1 858
TB TB

TB is an internet company.

Type: Startup Activities: healthtech Technologies: Synthetic Biology

6 2 1 866
Gaudenzia, Inc. Gaudenzia, Inc.

One goal, one passion – helping people break through substance use disorder. Gaudenzia, Inc. is one of the largest nonprofit substance use and co-occurring disorders treatment centers in the United States, with 51 facilities operating in Pennsylvania, Maryland, Delaware, and Washington, D.C. The agency serves more than 15,000 individuals annually and operates over 100 programs providing a full continuum of care. Everything we do is driven by a mission to meet clients where they are with evidence-based practices for substance use disorders so they can regain control of their lives and flourish in their communities. We put the needs of …

Type: SMB Activities: healthtech consumer services Technologies: Synthetic Biology

1 0 1 870
Mayoly Mayoly

[Automatic translation follows] Taking care to heart Through its subsidiaries, Mayoly is a family-owned, independent, French pharmaceutical and dermatological laboratory with an international footprint. For more than a century, it has successfully been growing its business with a focus on Gastroenterology and Dermocosmetics. Our French industrial heritage relates to our values ​​of Responsibility, Pragmatism and Caring. We strive passionately and tirelessly to provide patients and people with the best possible healthcare daily, and aim to establish ourselves as a leader in Consumer Healthcare over the coming decades Our know-how applies to several therapeutic areas, such as gastroenterology, rheumatology, ENT, general …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

8 1 2 878
23andMe 23andMe

23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers …

Type: Large company Activities: biotech deeptech Technologies: Synthetic Biology

20 3 4 888
Alvotech Alvotech

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

0 0 0 893
Daiichi Sankyo Europe GmbH Daiichi Sankyo Europe GmbH

Passion for Innovation. Compassion for Patients. Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

4 1 1 900
Suvoda Suvoda

IRT, eConsent, and eCOA solutions to help you wisely guide novel science through complex clinical trials Suvoda is a global clinical trial technology company that provides IRT, eConsent and eCOA software and services for complex, life-sustaining studies in therapeutic areas like oncology, central nervous system, and rare disease. Clinical trial management, Interactive response technology, Subject randomization, Trial supply management, IWRS, IRT, Interactive Web Response System, Clinical Supplies, Patient Logistics, and Clinical Supply Logistics

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

5 1 4 909
mAbxience mAbxience

From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

4 2 1 917
Schrödinger Schrödinger

Transforming drug discovery and materials research Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com.

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 926
Tentamus Group Tentamus Group

Global Network of specialized Laboratories - Labs for Life For more than a decade the Tentamus Group has been providing services to customers all over the world. Our quality and safety services focus on the testing, auditing and consulting of products that influence human well-being from within. The Tentamus Group is valued by many companies as a true service partner for a wide range of products with a high degree of quality and local understanding. More than 90 laboratories with more than 4,000 highly qualified employees are part of the Tentamus Group worldwide. Regardless of the size of our group, …

Type: SMB Activities: IT Services Technologies: Synthetic Biology

0 0 0 926
Insmed Incorporated Insmed Incorporated

Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. The Company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. Headquartered in Bridgewater, NJ, we are a rapidly growing company with offices in seven countries. Biotechnology, Orphan Disease State, Pharmaceuticals, Chronic Lung Infections, and Pulmonary

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 0 1 965
Genix Pharma (Private) Limited Genix Pharma (Private) Limited

Genix Pharma (Pvt.) Ltd is a leading Pharmaceutical manufacturer & marketing company, based in Pakistan with its business expanding throughout Asian & African Markets, after its establishment in 2004, Genix Pharma has been recognized as the fastest growing Pharmaceutical Company in its earliest years, it has been ranked among the top 40 companies including MNC’s, We have a work force of more than 1400 professionally trained and highly qualified employees, state of the art manufacturing facility, Well-furnished Quality Control department with top of the line and highly sophisticated Equipment, motivated by a passion to succeed, our company is committed to …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

0 0 0 1,010
Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc.

For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. We are guided by world-class scientists and business leaders whose great passion for innovation is equaled only by their focus and commitment to discover, develop and deliver medicines to the patients who depend on us. RNA-Targeted Therapeutics

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1,021
Inspire Medical Systems Inspire Medical Systems

We are committed to elevating and redefining the standard of care for Obstructive Sleep Apnea. Inspire Medical Systems, Inc. has developed the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea (OSA). The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient’s unique breathing patterns. Inspire therapy is designed to reduce OSA severity and improve quality of life for patients living with this challenging condition. Obstructive Sleep Apnea, ENT, sleep, patient engagement, digital health, medical device, medical devices, Sleep Apnea, Healthcare, …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

1 0 1 1,028
Standard BioTools Standard BioTools

Providing essential, standardized tools to accelerate breakthroughs in human health Microfluidics | Cytometry | Imaging Fluidigm is now Standard BioTools. A company and a name that reflects our commitment to you and your research ... To unleash the power of essential, standardized tools that help the life science industry develop breakthrough medicines faster and better. We are evolving to better meet the needs of our customers, bridging a robust and established portfolio of next-generation technologies with an experienced team of leaders dedicated to operational excellence. Standard BioTools – Unleashing reliable tools to accelerate breakthroughs in human health • Providing trusted …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

4 0 5 1,028
Twist Bioscience Twist Bioscience

Synthetic DNA for Health & Sustainability Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

7 1 6 1,061
Idorsia Pharmaceuticals Ltd Idorsia Pharmaceuticals Ltd

Reaching out for more! The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. See our LinkedIn community guidelines: https://www.idorsia.com/documents/com/policies-charters/idorsia-linkedin-community-guidelines.pdf Idorsia …

Type: Startup Activities: biotech Technologies: Synthetic Biology

1 1 0 1,122
Shockwave Medical Shockwave Medical

Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊 Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

2 2 1 1,123
WCG WCG

We improve lives by accelerating research, together. WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey. The pioneer of independent ethical review, now the industry gold standard, WCG’s 55-year legacy of independent review solutions serves as the foundation on which we continually build to accelerate and improve the clinical research journey. We lead the way by reimagining processes, optimizing quality and safety, strengthening productivity, and pioneering new solutions that leverage data and technology to accelerate research and impact global health. WCG liberates study stakeholders from the constraints that risk trial efficacy …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 0 1 1,243
Bavarian Nordic Bavarian Nordic

For us, it is all about improving and saving lives Improving and saving lives through innovative vaccines is at the heart of what we do in Bavarian Nordic, and we have more than 25 years of experience in developing life-saving vaccines. We are a fully integrated vaccine company focused on the development, manufacturing and commercialization of our vaccines, and our vision is to become one of the largest pure play vaccine companies in the world. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance the …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

2 1 2 1,311
AIG Hospitals AIG Hospitals

India's most advanced Multi Speciality Hospital with Superlative Care AIG Hospitals, Hyderabad AIG Hospitals is a unit of Asian Institute of Gastroenterology, India’s foremost Gastroenterology hospital. It is a state-of-the-art super specialty Hospital and is a world-leader to undertake Transplant surgeries including Liver, Kidney, Heart, Pancreas and Islet Cell. We believe in creating a positive and nurturing environment that is conducive to healing. Cardiology , Gastroenterology, Hepatology, Oncology, Neurology & Neurosurgery , Pulmonology, Andrology, Orthopedics, Multi-Organ Transplants, Nephrology, and Urology

Type: SMB Activities: healthtech Technologies: Synthetic Biology

0 0 0 1,442
COFARES COFARES

[Automatic translation follows] Health moves us Cofares is a company established with exclusively pharmaceutical capital that operates with the corporate formula of a cooperative. With a turnover in 2012 of more than 2.5 billion euros, it is the leading medicine distribution company in Spain. Medication distribution

Type: Large company Activities: deeptech Technologies: Synthetic Biology

4 1 4 1,492
Celltrion Inc Celltrion Inc

Celltrion is a leading biopharmaceutical company that specializes in research, development and manufacturing of innovative therapeutics. We are committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. We have been at the forefront of biotherapeutic development uncovering new ways of targeting the drivers of disease by creating next-generation biologics and small molecule products. For additional information on our guidelines, please visit: http://tinyurl.com/bdh9bxs9 To transform possibility into a reality by promoting the health and welfare of mankind. We thrive to meet the needs of people who previously had limited access to advanced therapeutics.

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

1 0 0 1,521
Selexis SA Selexis SA

Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1,671
Pharmaron Pharmaron

Premier life science service provider Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 20,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. Services: * …

Type: Large company Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1,743
10x Genomics 10x Genomics

Powering researchers’ insights with innovative single cell, spatial biology, & in situ tools. 🧬🔬 Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team …

Type: SMB Activities: Industry 4.0 IT Services Technologies: Synthetic Biology

0 0 0 2,072
Enovis Enovis

👋 #CreatingBetterTogether ➡ NYSE: ENOV We are a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, extraordinary talent and innovation, we ‘create better together’ by partnering with healthcare professionals. Our extensive range of products, services and integrated technologies fuel active lifestyles. orthopedics and animal health

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

1 0 1 2,605
SCIEX SCIEX

The Power of Precision SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 50 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers …

Type: Large company Activities: entertainment Technologies: Synthetic Biology

1 0 1 2,694
Natera Natera

We are a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. NateraTM is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment. Through a cfDNA …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

2 0 1 3,168
BioNTech SE BioNTech SE

Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To pioneer the next generation of patient-specific immunotherapies, we have combined ground-breaking research with cutting-edge technologies to develop therapeutics for cancer and beyond. Our broad and synergistic suite of platforms, which include mRNA therapeutics, engineered cell therapies, antibodies and small molecule immunomodulators have been optimized for distinct modes of action, high precision targeting, high potency and efficacy. We are also developing …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

38 17 8 4,420
Labcorp Drug Development Labcorp Drug Development

In Pursuit of Answers Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, we accelerate innovation and provide insight to improve health and improve lives. Whether you’re a patient, provider, researcher or in the pharmaceutical industry, we’re here for you. More than 70,000 employees strong, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY 2020. Learn more at www.Labcorp.com Drug Development Services , Toxicology Services, Central Labs, Central Laboratory Services , Clinical Trial Management , CRO …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

4 1 2 9,363
Tinnitracks Tinnitracks

Tinnitracks is a medical devices company based out of 30 Neuer Kamp, Hamburg-Sternschanze, Germany.

Type: Startup Activities: healthtech Technologies: Synthetic Biology

3 0 1 N/A
Groupe d'Étude et de Promotion des Protéines Végétales Groupe d'Étude et de Promotion des Protéines Végétales

[Automatic translation follows] Long live plant proteins! The GEPV, with the support of interprofessional organizations, supports the development of plant proteins by actively participating in a better knowledge of these products. VPMs (plant protein materials) are food ingredients derived from protein-rich plant species, such as legume seeds (soybean, udder, lupine, faba bean) and cereal seeds (wheat).

Type: SMB Activities: foodtech Technologies: Synthetic Biology

5 1 5 N/A
Auto21 Auto21

[Automatic translation follows] Cars and mobility of the 21st century

Type: Startup Activities: transporttech Technologies: Synthetic Biology

0 0 0 N/A
IMODI Cancer IMODI Cancer

Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient. French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...) 3 major R&D axes: - Developing in vivo models and cell-based assays - Mimicking the human biology by humanizing the tumor microenvironment in mice - Studying the microbiota in cancer patients Oncology, Cancer research, Patient derived Xenograft, Cell lines, Ex vivo assays, Microbiota, Data mining , Translationnal medecine, Humanized mice, Biomarker, Research and Development, In vivo models, Ex vivo models, and Cancer

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 0 N/A
SOLNATIDE project SOLNATIDE project

H2020 project exploring safety, tolerability and clinical efficacy of solnatide IMP in COVID-19 patients. The SOLNATIDE project will clinically test the safety, tolerability and clinical efficacy of solnatide IMP in patients with severe COVID-19 requiring mechanical ventilation. APEPTICO’s lead-compound solnatide IMP has been designed for the therapeutic treatment of patients with Acute Respiratory Distress Syndrome (ARDS) and various forms of Pulmonary Oedema (PPO). Orally inhaled solnatide has delivered clinical proof-of-concept in one Phase I and two Phase IIa clinical studies (EUDRACT No. 2011-000223-33, 2012-001863-64 and 2013-000716-21). Currently, solnatide is subject to a Phase IIB trial (EUDRACT No. 2017-003855-47) being approved …

Type: Startup Activities: deeptech Technologies: Synthetic Biology

0 0 0 N/A
Nanna Therapeutics Nanna Therapeutics

Totally Integrated Medicines Engine (TIME) to Cure Diseases

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 N/A
Pludi EU Pludi EU

#plant #biotech #verticalfarm Biotechnology research and development

Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology

0 0 0 N/A
USC USC

The official Twitter account of the University of Southern California. #USC | #FightOn

Type: SMB Activities: deeptech Technologies: Synthetic Biology

43 13 5 N/A
Capital Cell Capital Cell

[Automatic translation follows] https://t.co/YVyBFPnY4V

Type: SMB Activities: deeptech Technologies: Synthetic Biology

16 1 9 N/A
Pietro Turilli Pietro Turilli

Senior Vice President, External Affairs at the TB Alliance. Helping to build the political will and mobilize resources necessary to end TB. Views are my own.

Type: SMB Activities: deeptech Technologies: Synthetic Biology

0 0 0 N/A
Elektronik medical Elektronik medical

[Automatic translation follows] Innovative products and solutions for medical technology Far beyond product reporting, Elektronik medical offers developers, designers and management valuable specialist knowledge about medical technology and medical device development. Medical technology and technology

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

11 0 11 N/A
PharmaLex PharmaLex

Delivering Success with Confidence

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 N/A
American Gene™ American Gene™

A cell & #genetherapy company with a #gene delivery platform to develop cures to #cancer #HIV #PKU. In Phase 1 trial for #HIVcure. CEO @JeffreyGalvin.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 N/A
NovioSense BV NovioSense BV

NovioSense BV is a spin out company from Fraunhofer Gesellschaft and NovioTech BV based in Nijmegen. NovioSense is a wireless platform technology for non-invasive monitoring of disease biomarkers. The first sensor based on the NovioSense technology is a wireless non-invasive glucose sensor. Development is targeted at a clinical prototype for non-invasive continuous monitoring of glucose levels in tear fluid. Medical Devices, Sensor Development, Diabetes, and Medical Technology

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 N/A
aVaxziPen aVaxziPen

aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens.

Type: Startup Activities: deeptech Technologies: Synthetic Biology

0 0 0 N/A
Interreg Mattisse Interreg Mattisse

[Automatic translation follows] 3D matrices for tissue reconstruction Application to breast reconstruction The MAT(T)ISSE project proposes to create a new bioprosthesis, a class 3 implantable medical device, which aims to help the body restore damaged regions following curative surgical interventions. This tissue restoration is carried out through the autologous collection of fat cells (adipose tissue) re-implanted on a synthetic and resorbable lace-type textile structure. The textile structure has a role of maintenance, assistance in the multiplication of implanted fat cells and revascularization. It is coupled with a bioresorbable and personalized 3D shell which delimits the volume to be reconstructed. Ultimately, …

Type: Startup Activities: deeptech Technologies: Synthetic Biology

2 2 0 N/A
Genvade Therapeutics Genvade Therapeutics

Dedicated to developing treatments for rare diseases originated from nonsense mutations Genvade aims to harness the power of nonsense mutation readthrough molecules to develop treatments for some of the most burdensome rare diseases. Our lead compound targets indications include cystic fibrosis, Duchenne muscular dystrophy and other genetic diseases. small molecules, drug discovery and development, rare diseases, nonsense mutation corrector, cystic fibrosis, genetic diseases, oncology, readthrough, and Duchenne

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 2 0 N/A
Pomega Laboratories Pomega Laboratories

New Natural & Ethical Anti Inflammatory Pharmaceutical Products Natural Products with Proven Health Claims For PETS. Pomega develops a novel, safe, ethical and non-toxic therapy that retards disease progression by inhibiting cartilage breakdown at an earlier stage. Product is developed by skilled pharmacist under drug standards frame First product coming out the pipeline is Ω-344 Product , a patented fruit extract with strong anti inflammatory properties osteoarthritis , anti inflammatory, fruit extract, inflammation, arthritis, biotech, NSAIDs, pain, animal, dogs, pets, wellness, healthcare, petfood, and cats

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 1 0 N/A
ISOSTEM ISOSTEM

Innovating Biologics ISOSTEM is a medical devices company based out of TEMIS CENTER 1 17 F RUE ALAIN SAVARY, BESANCON, France.

Type: SMB Activities: healthtech Technologies: Synthetic Biology

0 0 0 N/A
DimiCare Biotech DimiCare Biotech

goes FAR BEYOND (Fighting Antimicrobial Resistance to the Biological EmergencY to Opportunistic and Neglected Diseases) Dimicare Biotech is a project from INSERM and Université Côte d'Azur focused on the development of novel "precision" antimicrobial drugs to fight multidrug-resistant infections. Our main project focuses on the development of a new treatment against multidrug-resistant S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus strains). Currently, this treatment is in the early-preclinical phase where its efficacity against several clinical strains and its innocuity in Human cells has been confirmed. Dimicare Biotech is building a great team involving Microbiology Medical doctors, Fundamental …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

7 2 0 N/A
AXIOS Senolytics AXIOS Senolytics

[Automatic translation follows] Innovation for your health and well-being. Pharmaceutical company, R&D oriented dedicated to the development and marketing of senolytic compounds, food supplements and drugs against aging, age-related degenerative diseases and cancer.

Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

1 1 0 N/A
NLS Pharma NLS Pharma

NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 N/A